Back to today’s briefing

Story perspectives

Diabetes Care Transformed: Tirzepatide Surges, Metformin Declines

4/15/2025

35 2

Summary

Story summary

A groundbreaking study reveals a surge in the use of tirzepatide and other modern diabetes medications since its US launch on May 13, 2022. As patients increasingly turn to these innovative treatments, traditional options like metformin are falling out of favor, signaling a pivotal shift in diabetes care that could reshape health policy for years to come.

1 of 1

Story summary

A groundbreaking study reveals a surge in the use of tirzepatide and other modern diabetes medications since its US launch on May 13, 2022. As patients increasingly turn to these innovative treatments, traditional options like metformin are falling out of favor, signaling a pivotal shift in diabetes care that could reshape health policy for years to come.